Finasteride (Proscar, Propecia) is used to treat male pattern hair loss or benign prostatic hyperplasia. Learn about side effects, warnings, dosage, and more.

Finasteride and spironolactone suitability varies based on hormonal status. For premenopausal women, spironolactone is often preferred due to its anti-androgenic properties, which help manage hair ...

Dutasteride and finasteride are two popular 5alpha-reductase inhibitors that are used to treat BPH. These drugs prevent male hormones from increasing the size of your prostate.

Rogaine Finasteride, which is sold as Proscar or Propecia, was approved by the FDA in the ’90s. An estimated 2.6 million people took finasteride in 2022.

MasterPharm recalled one lot of Finasteride Plus, a hair loss drug that comes in capsules. It has too much minoxidil, which isn’t named in the ingredients. Heart failure or heart damage can result.

Thompson IM et al. The influence of finasteride on the development of prostate cancer. N Engl J Med 2003 Jul 17; 349:215-24. Scardino PT. The prevention of prostate cancer -- The dilemma continues.

Finasteride is also taken to treat men with large prostate glands. The drug works by blocking a protein in hair follicles and the prostate gland that activates testosterone.

As you mentioned, one side effect of inhibiting DHT is erectile dysfunction. DHT appears to play a significant role in erection as seen from multiple animal studies, and the use of finasteride and ...

Key takeaways: FDA warned of potential serious risks when using compounded topical finasteride. There are no FDA-approved topical formulations of the drug. The FDA issued an alert warning of ...

Both Propecia and Proscar are manufactured by Merck. Previous research has tied the drug to sexual side effects, and in April 2012, the U.S. Food and Drug Administration added warning labels to ...

Raw data from the Prostate Cancer Prevention Trial were used to model chemopreventive treatment strategies: treat all men, treat no men, or treat a high-risk subgroup based on PSA level. We weighted ...